Day One Biopharmaceuticals Inc. (DAWN) Statistics & Valuation Metrics - Stocknear

Day One Biopharmaceutical...

NASDAQ: DAWN · Real-Time Price · USD
6.77
0.09 (1.35%)
At close: Sep 26, 2025, 3:59 PM
6.97
2.95%
After-hours: Sep 26, 2025, 07:49 PM EDT

Day One Biopharmaceuticals Statistics

Share Statistics

Day One Biopharmaceuticals has 102.43M shares outstanding. The number of shares has increased by 15.5% in one year.

102.43M
15.5%
0.01%
83.3%
78.72M
929
0.06%

Short Selling Information

The latest short interest is 11.22M, so 10.96% of the outstanding shares have been sold short.

11.22M
10.96%
16.22%
13.09

Valuation Ratios

The PE ratio is -12.42 and the forward PE ratio is -8.46. Day One Biopharmaceuticals's PEG ratio is 0.22.

-12.42
-8.46
9.04
3.2
2.36
-14.78
0.22
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Day One Biopharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 7.66, with a Debt / Equity ratio of 0.01.

7.66
7.61
0.01
-0.01
-0.03
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$724.65K
$-527.6K
181
0.23
1.59

Taxes

-7.14M
8.09%

Stock Price Statistics

The stock price has increased by -52.19% in the last 52 weeks. The beta is -1.25, so Day One Biopharmaceuticals's price volatility has been lower than the market average.

-1.25
-52.19%
6.91
8.52
43.35
1,510,276

Income Statement

In the last 12 months, Day One Biopharmaceuticals had revenue of 131.16M and earned -95.5M in profits. Earnings per share was -1.02.

131.16M
125.88M
-217.27M
-95.5M
-217.27M
-88.35M
-1.02
Full Income Statement

Balance Sheet

The company has 124.97M in cash and 2.6M in debt, giving a net cash position of 122.37M.

124.97M
2.6M
122.37M
-554.08M
519.04M
443.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -78.11M and capital expenditures -2.17M, giving a free cash flow of -80.28M.

-78.11M
-2.17M
-80.28M
-0.86
Full Cash Flow Statement

Margins

Gross margin is 95.98%, with operating and profit margins of -165.65% and -72.81%.

95.98%
-165.65%
-67.36%
-72.81%
-165.65%
-165.65%
-61.21%

Dividends & Yields

DAWN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for DAWN is $27, which is 298.8% higher than the current price. The consensus rating is "Buy".

$27
298.8%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

6.77
3